Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-10-03 00:00:00 ET · period of report 2023-09-29 · accession 0001209191-23-051408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-03 | 2023-09-29 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $350.72 | -408 | 11.2K | -4% | -$143.1K | |
| 2023-10-03 | 2023-10-02 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $346.76 | -610 | 10.6K | -5% | -$211.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-29 | F | D | 408 | $350.72 | 11,179 | D | — | — | |
| 2 | Common | Common Stock | 2023-10-02 | S | D | 610 | $346.76 | 10,569 | D | — | — |